Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
All news about
 
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Investors look to Lighten Up on Shares of Biosante Pharmaceuticals, Shares Down 14.1% (BPAX)
June 01, 2012
from Comtex SmarTrend® News Briefs
BioSante Pharmaceuticals Announces Reverse Stock Split in Order to Maintain NASDAQ Listing
May 31, 2012
from Business Wire News Releases
Biosante Pharma (BPAX) Volatility Elevated on Trader Profit Taking
May 22, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7462412 for the full story. Read More
from StreetInsider.com News Articles
Nasdaq Up Big Despite Facebook (FB) Blunder
May 21, 2012
The Nasdaq Composite Index totally botched the Facebook IPO. Even the exchange’s chief executive said so, saying he was “embarrassed” that technical glitches by the Nasdaq forced the social network to... Read More
from Wyatt Investment Research
Biosante Pharma (BPAX) Volatility Up as Shares Run Nearly 50%
May 21, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7458550 for the full story. Read More
from StreetInsider.com News Articles
Traders Get Bullish on Shares of Biosante Pharmaceuticals, Shares Up 17.6% (BPAX)
May 21, 2012
from Comtex SmarTrend® News Briefs
Biosante Pharmaceuticals: The Losing Streak Continues (BPAX)
May 18, 2012
from Comtex SmarTrend® News Briefs
Recent 52-Week Low Surpassed in Shares of Biosante Pharmaceuticals (BPAX)
May 17, 2012
from Comtex SmarTrend® News Briefs
Ceregene Parkinson's Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
May 17, 2012
First Evidence for Long Term, Biologically Active Protein Expression in the Human Brain by Gene Therapy Read More
from PR Newswire
BioSante Pharmaceuticals, Inc. (BPAX) Long-Term Investor Alert: Lawsuit Against Directors
May 14, 2012
San Diego, CA -- (SBWIRE) -- 05/14/2012 -- A lawsuit was filed by a current investor in NASDAQ:BPAX shares over alleged breaches of fiduciary duties and current long-term NASDAQ:BPAX stockholders... Read More
from SBWire - Latest Press Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
May 14, 2012
from GlobeNewswire News Releases
Hot Stock: Biosante Pharmaceuticals, Shares Drop 11.6% (BPAX)
May 09, 2012
from Comtex SmarTrend® News Briefs
Shareholder Rights Law Firm Johnson & Weaver, LLP Investigates Biosante Pharmaceuticals, Inc. for Securities Fraud
May 09, 2012
from Business Wire News Releases
BioSante Pharmaceuticals Reports First Quarter Financial Results
May 08, 2012
from Business Wire News Releases
Biotech Takeovers: Who’s Next On The Block?
May 04, 2012
While most sectors see their constituents moved by more benign news such as earnings reports, dividend increases/decreases, share repurchases, insider buying/selling and scores of other typical... Read More
from TradersHuddle.com
Small Biotech Companies Look to Benefit From Shift to "First to File" Patent System
May 03, 2012
The Paragon Report Provides Stock Research on Biosante Pharmaceuticals and Advanced Cell Technology Read More
from Marketwired News Releases
Pharmaceutical Companies Look to Biotech Industry to Combat Losses From Expiring Patents
April 23, 2012
The Paragon Report Provides Stock Research on Biosante Pharmaceuticals Inc. and Exelixis, Inc. Read More
from Marketwired News Releases
BioSante Pharmaceuticals, Inc. to Present at BioCentury Future Leaders in the Biotech Industry Conference
April 17, 2012
from Business Wire News Releases
Galena Biopharma Inc. (GALE) is a Monster Biotech in the making, According to MonsterOTC.com
April 05, 2012
from EmailWire.Com Press Releases
Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors With Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to
April 04, 2012
from PR Newswire
INVESTOR ALERT: Approximately 48 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Large Financial Interests of Important Deadline in Lawsuit Against Bio
April 04, 2012
from Marketwired News Releases
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) Investor Alert: Deadline on April 6
April 04, 2012
San Diego, CA -- (SBWIRE) -- 04/04/2012 -- A Deadline is coming up on April 6, 2012 in lawsuit for investors in BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) and NASDAQ:BPAX stockholders should contact... Read More
from SBWire - Latest Press Releases
Galena Biopharma Inc. (GALE) Will Make Shorts Pay, Reports Thestockfather.com
April 04, 2012
from EmailWire.Com Press Releases
Deadline Approaching: The Law Firm of Levi & Korsinsky Notifies Investors with Losses on Their Investment in BioSante Pharmaceuticals, Inc. of Class Action Lawsuit and the Deadline of April 6, 2012 to
April 03, 2012
from Business Wire News Releases
BioSante Pharmaceuticals Alert: The Briscoe Law Firm and Powers Taylor, LLP Investigate Possible Breaches of Fiduciary Duty by the Officers and Directors of BioSante Pharmaceuticals, Inc.
March 29, 2012
from Business Wire News Releases
BioSante (BPAX) Reports Encouraging Data from Recent Pill-Plus Studies
March 20, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7281856 for the full story. Read More
from StreetInsider.com News Articles
BioSante Pharmaceuticals Announces Positive Pill-Plus™ Data Presentation
March 20, 2012
from Business Wire News Releases
FAST Act to Modernize Approval Process -- Cardium and BioSante Poised to Benefit
March 19, 2012
The Paragon Report Provides Equity Research on Cardium Therapeutics & BioSante Pharmaceuticals Read More
from Marketwired News Releases
BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) Investor Lawsuit Deadline on April 6
March 14, 2012
San Diego, CA -- (SBWIRE) -- 03/14/2012 -- A Deadline is coming up on April 6, 2012 in lawsuit for investors in BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) and NASDAQ:BPAX stockholders should contact... Read More
from SBWire - Latest Press Releases
BioSante Pharmaceuticals (BPAX) Report FY11 Financials
March 13, 2012
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=7266339 for the full story. Read More
from StreetInsider.com News Articles
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here